55 results
424B3
ALIM
Alimera Sciences Inc.
12 Jul 23
Prospectus supplement
12:00am
, subject to applicable community property laws.
Beneficial OwnershipBefore the Offering
Maximum Number of Shares that may be Offered and Sold
8-K
EX-2.1
lksovaivc9m m5cz
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
8-K
6p5 jx6twyn52yeid
14 Nov 22
Alimera Sciences Announces Third Quarter 2022 Financial Results
8:34am
8-K
EX-99.1
n0k1ijw 68j1mr8
1 Dec 21
Alimera Sciences Welcomes Ophthalmic Strategic Consultant
8:27am
424B5
b3lg07wcn
28 Nov 14
Prospectus supplement for primary offering
12:00am